Pharma Says "What Crisis?"

This morning, Pfizer announced that it has agreed to acquire Wyeth. Consideration will amount to about $50 per Wyeth share in cash and stock. Total price is $68 million. No SEC disclosure so far, though both companies released their 2008 financials this morning. Both made money. The New York Times has a good article pointing out that this merger is unusual because (a) banks, not the federal government, loaned money and (b) both companies are doing well. Just like the halcyon days of old.